Cite

    Beksac, A. et al. (2022). Unified model involving genomics, magnetic resonance imaging and prostate‐specific antigen density outperforms individual co‐variables at predicting biopsy upgrading in patients on active surveillance for low risk prostate cancer. Cancer reports. 5 (3), p. n/a. [Online].